KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $938 | -25.1% | 700 | 0.0% | 0.00% | – |
| Q2 2023 | $1,253 | -54.0% | 700 | 0.0% | 0.00% | – |
| Q1 2023 | $2,723 | +14.4% | 700 | 0.0% | 0.00% | – |
| Q4 2022 | $2,380 | -40.5% | 700 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 700 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 700 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 700 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | 0.0% | 700 | -12.5% | 0.00% | – |
| Q3 2021 | $5,000 | -37.5% | 800 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $8,000 | 0.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $8,000 | -11.1% | 800 | +33.3% | 0.00% | 0.0% |
| Q4 2020 | $9,000 | 0.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,000 | -18.2% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | +10.0% | 600 | +20.0% | 0.00% | 0.0% |
| Q1 2020 | $10,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |